首页|2014~2019年北京某三甲医院腹腔感染革兰阴性菌的耐药情况与合理用药的探讨

2014~2019年北京某三甲医院腹腔感染革兰阴性菌的耐药情况与合理用药的探讨

扫码查看
目的:通过对北京某三甲医院2014~2019年期间采集的腹腔感染革兰阴性菌的鉴定和对常用抗菌药物的药敏测试,为近年院内腹腔感染革兰阴性菌的流行病学和耐药情况提供参考依据.方法:使用定制药敏板通过Trek系统进行抗菌药物敏感性测试并依据CLSI2021标准进行药敏判读.结果:2014~2019年期间共收集革兰阴性菌464株,其中肠杆菌目细菌355株,社区获得性感染菌株123株、医院获得性感染菌株341株,ICU收集的菌株187株.药敏试验显示:该院碳青霉烯类抗菌药物耐药菌中,大肠埃希菌对目前国内常用的12种抗菌药物几乎都呈现不敏感状态,仅阿米卡星的敏感率为81.8%;除黏菌素外,肺炎克雷伯菌几乎无抗菌药物可选择;铜绿假单胞菌目前对环丙沙星、头孢吡肟、阿米卡星的敏感率均为75.0%.该院喹诺酮类抗菌药物耐药菌中,对大肠埃希菌治疗有效率达到82.5%及以上的抗菌药物有厄他培南、亚胺培南、美罗培南、阿米卡星和黏菌素;亚胺培南、美罗培南和阿米卡星对肺炎克雷伯菌的敏感率仅在65.0%左右;对于铜绿假单胞菌,可选的抗菌药物有头孢他啶、头孢吡肟和阿米卡星(敏感率均为66.7%).该院第三代头孢菌素耐药菌中,大肠埃希菌对亚胺培南、美罗培南、阿米卡星和黏菌素的敏感率均在93.0%以上;肺炎克雷伯菌对亚胺培南、美罗培南和阿米卡星的敏感率在71.4%~79.2%;铜绿假单胞菌对环丙沙星、美罗培南、阿米卡星和黏菌素的敏感率在83.3%以上.无论是碳青霉烯类抗菌药物耐药鲍曼不动杆菌,还是喹诺酮类抗菌药物耐药鲍曼不动杆菌,或者是第三代头孢菌素耐药鲍曼不动杆菌,除黏菌素的敏感率为97.6%~100.0%外,几乎无常规抗菌药物可供选择.结论:腹腔感染革兰阴性菌总体耐药形势比较严峻,持续监测本地区医院病原菌检出率和合理选择对耐药菌株有效的抗菌药物治疗非常重要.
Resistance Patterns and Rational Drug Use in Gram-Negative Bacterium in Intra-Abdominal Infections in a Tertiary Hospital in Beijing from 2014 to 2019
Objective:To provide reference for epidemiology and resistance patterns of Gram-negative bacterium in intra-abdominal infections in recent years by identification and testing of susceptibility to commonly used antibiotics using Gram-negative isolates from intra-abdominal infection collected from a tertiary hospital in Beijing from 2014 to 2019.Methods:Antimicrobial susceptibility testing was performed using the Trek system,and the susceptibility interpretation was performed according to the CLSI 2021.Results:From 2014 to 2019,a total of 464 Gram-negative bacterial isolates were collected,including 355 isolates of Enterobacteriaceae,123 isolates from community-acquired infections,341 isolates from hospital-acquired infections and 187 isolates from ICU.The results of susceptibility testing showed that among carbapenem-resistant bacterium in this hospital,Escherichia coli strains were not susceptible to 12 antibiotics which are currently commonly used in China,with the only susceptibility identified with amikacin,and its susceptible rate was 81.8%;There are few available alternative antibiotics for Klebsiella pneumoniae except colistin;At present,the susceptibility rates of ciprofloxacin,cefepime and amikacin to Pseudomonas aeruginosa were all 75.0%.For the quinolone-resistant bacterium in this hospital,ertapenem,imipenem,meropenem,amikacin and colistin were the antibiotics with an effective rate of over 82.5%against Escherichia coli.The susceptibility rates of imipenem,meropenem and amikacin to Klebsiella pneumoniae were only about 65.0%.For Pseudomonas aeruginosa,the available antibiotics were ceftazidime,cefepime and amikacin(susceptibility rate of 66.7%each).Among the third generation cephalosporin-resistant strains,the susceptibility rates were above 93.0%for imipenem,meropenem,amikacin and colistin against Escherichia coli,ranged from 71.4%to 79.2%for imipenem,meropenem and amikacin against Klebsiella pneumoniae,and were over 83.3%for ciprofloxacin,meropenem,amikacin and colistin against Pseudomonas aeruginosa.For any of carbapenem-resistant,quinolone-resistant or third-generation cephalosporin-resistant Acinetobacter baumannii,there are few available common antibiotics except colistin,which exhibited a susceptibility rate of 97.6%to 100%.Conclusion:The overall drug resistance of Gram-negative bacterium in intra-abdominal infections is severe,hence it is of great importance to continuously monitor the detection rate of pathogens in local hospitals and select effective antibiotic therapy for drug-resistant strains.

Gram-negative bacteriumgerms in enterobacterales ordernon-fermentative Gram-negative bacteriumantibioticsdrug resistance

陈曦、毛熠、王鹏、刘慧宇、杨春霞

展开 >

首都医科大学附属北京朝阳医院感染和临床微生物科,北京 100020

默沙东(中国)投资有限公司全球医学事务部,上海 200233

革兰阴性菌 肠杆菌目细菌 不发酵糖革兰阴性菌 抗菌药物 耐药

2024

中国合理用药探索
中国执业药师协会

中国合理用药探索

影响因子:0.62
ISSN:2096-3327
年,卷(期):2024.21(7)